A phase two study of high dose blinatumomab in Richter's syndrome.
Thompson PA, Jiang X, Banerjee P, Basar R, Garg N, Chen K, Kaplan M, Nandivada V, Cortes AKN, Ferrajoli A, Keating MJ, Peterson CB, Andreeff M, Rezvani K, Wierda WG.
Thompson PA, et al. Among authors: peterson cb.
Leukemia. 2022 Sep;36(9):2228-2232. doi: 10.1038/s41375-022-01649-3. Epub 2022 Aug 8.
Leukemia. 2022.
PMID: 35941212
Free PMC article.
Clinical Trial.